Key Financial Data
| Key Data | Net Sales |
| Sales by Business | Pharmaceuticals: Net Sales |
| Key P&L and Cash Flow | Balance Sheet Structure |
| Per Share Data | |
Key Data
| (m €) | ||||||
|---|---|---|---|---|---|---|
| 2005 | 2006 | 2007 | 2008 | 2009 | ||
| Net Sales | 576.1 (100%) |
576.2 (100%) |
628.4 (100%) |
689.6 (100%) |
747.5 (100%) | |
| Operating Income | 111.1 (19.3%) |
120.3 (20.9%) |
131.5 (20.9%) |
144.7 (21.0%) |
162.2 (21.7%) | |
| Net Income | 64.5 (11.2%) |
74.0 (12.8%) |
84.9 (13.5%) |
100.4 (14.6%) |
110.6 (14.8%) | |
Net Sales
Sales by Business
Pharmaceuticals: Net Sales
Key P&L and Cash Flow
| (m €) | ||||||
|---|---|---|---|---|---|---|
| 2005 | 2006 | 2007 | 2008 | 2009 | ||
| Net Sales | 576.1 | 576.2 | 628.4 | 689.6 | 747.5 | |
| Gross profit as % of Sales |
375.5 65.2% |
384.2 66.7% |
422.1 67.2% |
467.4 67,8% |
511.9 68,5% | |
| Operating Income (EBIT) as % of Sales |
111.1 19.3% |
120.3 20.9% |
131.5 20.9% |
144.7 21.0% |
162.2 21.7% | |
| Pretax Income | 107.0 | 118.2 | 127.4 | 138.1 | 152.7 | |
| Net Income | 64.5 | 74.0 | 84.9 | 100.4 | 110.6 | |
| CASH FLOW | 89.0 | 97.3 | 113.7 | 140.3 | 149.2 | |
Balance Sheet Structure
Per Share Data
| 2005 | 2006 | 2007 | 2008 | 2009 | |
| Earnings per share (EPS) | 0.326 | 0.370 | 0.427 | 0.511 | 0.561 |
|---|---|---|---|---|---|
| Shareholders'equity per share | 1.621 | 1.836 | 1.989 | 2.262 | 2.575 |
